help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 10, 2005
Endocrinology, doi:10.1210/en.2004-1667
A more recent version of this article appeared on May 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
146/5/2406    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barbu, A. R.
Right arrow Articles by Welsh, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barbu, A. R.
Right arrow Articles by Welsh, N.

Submitted on December 27, 2004
Accepted on January 31, 2005

Adenoviral-mediated transduction of human pancreatic islets; importance of adenoviral genome for cell viability and association with a deficient antiviral response

Andreea R. Barbu*, Göran Akusjärvi, and Nils Welsh

Department of Medical Cell Biology, Uppsala University, S-751 23 Uppsala, Sweden; Department of Medical Biochemistry and Microbiology, Uppsala University, S-751 23 Uppsala, Sweden

* To whom correspondence should be addressed. E-mail: Andreea.Barbu{at}medcellbiol.uu.se.

As adenoviral vectors are extensively used for genetic manipulation of insulin producing cells in vitro there is an increasing need to evaluate their effects on the function, morphology and viability of transduced pancreatic islets. In the present study, we observed that specific adenoviral genotypes, carrying E4- and E1/E3-deletions correlate with differential induction of necrosis in pancreatic islet cells. In particular, the adenovirus death protein encoded from the E3-region of the adenoviral genome was able to modulate the changes induced in the morphology and viability of the transduced cells. We also propose a putative role for the transcriptional regulator pIX. Although human islet cells showed an increased resistance in terms of viral concentrations required for the induction of cell-toxicity, our results showed that they were unable to build up an efficient antiviral response following transduction and that their survival was dependent on the exogenous addition of {alpha}-interferon. An intact and fully functional {beta}-cell is crucial for the successful application of gene therapy approaches in type 1 diabetes and therefore, the implications of our findings need to be considered when designing vectors for gene transfer into pancreatic {beta}-cells.


Key words: {beta}-cell death • gene therapy • adenoviral vector • IFN-{alpha}




This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
R. Takahashi, H. Ishihara, K. Takahashi, A. Tamura, S. Yamaguchi, T. Yamada, H. Katagiri, and Y. Oka
Efficient and controlled gene expression in mouse pancreatic islets by arterial delivery of tetracycline-inducible adenoviral vectors
J. Mol. Endocrinol., January 1, 2007; 38(1): 127 - 136.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society